Premium
Synthetic Fusion Protein CAR Technology to Redirect T Cell Antigen Specificity to Promote Organ Transplant Tolerance
Author(s) -
Brouard S.,
Mooney N.
Publication year - 2017
Publication title -
american journal of transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.89
H-Index - 188
eISSN - 1600-6143
pISSN - 1600-6135
DOI - 10.1111/ajt.14211
Subject(s) - medicine , context (archaeology) , il 2 receptor , immunology , transplantation , organ transplantation , chimeric antigen receptor , antigen , population , t cell , cancer research , immune system , biology , paleontology , environmental health
In response to the article by Boardman et al ( page 931), the authors provide a brief update on chimeric antigen receptor technology, particularly regarding regulatory T cells in the context of transplantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom